Literature DB >> 27548430

The Search for Causative Environmental Factors in Inflammatory Bowel Disease.

Gerhard Rogler1, Jonas Zeitz, Luc Biedermann.   

Abstract

Inflammatory bowel disease (IBD) has become a 'prototype disease' for chronic auto-inflammatory disorders with a polygenic background and important multifaceted environmental trigger components. The environmental factors contribute both to pathogenesis and disease flares. Thus, IBD is a disease par excellence to study the interactions between host genetics, environmental factors (such as infections or smoking) and 'in-vironmental' factors - for example, our intestinal microbiota. Longitudinal intercurrent events, including the impact of long-term medication on disease progression or stabilization, can exemplarily be studied in this disease group. Whilst alterations in the human genome coding relevant variant protein products have most likely not emerged significantly over the last 50 years, the incidence of Crohn's disease and ulcerative colitis has dramatically increased in Western countries and more recently in the Asia Pacific area. An interesting concept indicates that 'Western lifestyle factors' trigger chronic intestinal inflammation or disease flares in a genetically susceptible host. To understand the disease pathogenesis as well as triggers for flares or determinants of disease courses, we must further investigate potential en(in)vironmental factors. As environmental conditions, in contrast to genetic risk factors, can be influenced, knowledge on those risk factors becomes crucial to modulate disease incidence, disease course or clinical presentation. It is obvious that prevention of environmentally triggered disease flares would be a goal most relevant for IBD patients. An increased prevalence of IBD in urban environment has been documented in Switzerland by the Swiss IBD cohort study. Several studies have attempted to identify such factors; however, only a few have been validated. The best investigated environmental factor identified in IBD cohort analyses is smoking. Other environmental factors that have been associated with clinical presentation or risk of inflammatory flares as well as increased incidence are diet and food additives. The so-called 'hygiene hypothesis' suggests that increased hygiene in childhood associated with reduced exposure to pathogens may leave the mucosal immune system insufficiently trained and thus prone to uncontrolled inflammation. Oral contraceptives and non-steroidal anti-inflammatory drugs are the 2 main classes of frequently taken drugs that have been attributed to have the potential to cause flares of the disease. What is likely to be the connection between the genetic susceptibility and the environmental triggers? There is broad evidence for a critical role of the commensal enteric microbiota as a modulator of immunologic responses relevant during onset and chronification of IBD.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27548430     DOI: 10.1159/000447283

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  14 in total

Review 1.  Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Authors:  Glenn R Gibson; Robert Hutkins; Mary Ellen Sanders; Susan L Prescott; Raylene A Reimer; Seppo J Salminen; Karen Scott; Catherine Stanton; Kelly S Swanson; Patrice D Cani; Kristin Verbeke; Gregor Reid
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-14       Impact factor: 46.802

2.  Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3.

Authors:  Xingyu Ma; Qianqian Di; Xiaoli Li; Xibao Zhao; Ruihan Zhang; Yue Xiao; Xunwei Li; Han Wu; Haimei Tang; Jiazheng Quan; Zherui Wu; Weilie Xiao; Weilin Chen
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial.

Authors:  Alireza Milajerdi; Omid Sadeghi; Seyed Davar Siadat; Seyed Ali Keshavarz; Alireza Sima; Homayoon Vahedi; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Trials       Date:  2020-02-18       Impact factor: 2.279

4.  Neonatal immune challenge followed by adult immune challenge induces epigenetic-susceptibility to aggravated visceral hypersensitivity.

Authors:  J E Aguirre; J H Winston; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2017-04-25       Impact factor: 3.598

5.  Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.

Authors:  Elizabeth Liles; Stephanie A Irving; Padma Dandamudi; Edward A Belongia; Matthew F Daley; Frank DeStefano; Lisa A Jackson; Steven J Jacobsen; Elyse Kharbanda; Nicola P Klein; Eric Weintraub; Allison L Naleway
Journal:  Vaccine       Date:  2021-05-26       Impact factor: 3.641

Review 6.  Diet and microbiota in inflammatory bowel disease: The gut in disharmony.

Authors:  Davy C M Rapozo; Claudio Bernardazzi; Heitor Siffert Pereira de Souza
Journal:  World J Gastroenterol       Date:  2017-03-28       Impact factor: 5.742

7.  Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.

Authors:  A Hünerwadel; S Fagagnini; G Rogler; C Lutz; S U Jaeger; C Mamie; B Weder; P A Ruiz; M Hausmann
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379

8.  THE EFFECT OF DAILY PHYSICAL ACTIVITY ON THE ACTIVITY OF INFLAMMATORY BOWEL DISEASES IN THERAPY-FREE PATIENTS.

Authors:  Dubravka Holik; Aleksandar Včev; Andrea Milostić-Srb; Željka Salinger; Zrinka Ivanišević; Ivan Včev; Maja Miškulin
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

9.  [rCsHscB derived from Clonorchis sinensis has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice].

Authors:  H Hua; X Dong; Y Zhang; F Fang; B Zhang; X Li; Q Yu; K Zheng; C Yan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20

10.  Disruption of GPR35 Exacerbates Dextran Sulfate Sodium-Induced Colitis in Mice.

Authors:  Shukkur M Farooq; Yuning Hou; Hainan Li; Megan O'Meara; Yihan Wang; Chunying Li; Jie-Mei Wang
Journal:  Dig Dis Sci       Date:  2018-07-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.